MIR8061

Across TCGA pan-cancer cohorts, MIR8061 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR8061 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR8061 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR8061 expression acts as an unfavorable survival marker.

DLBC, THCA, and LUAD are the cancer types where MIR8061 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.115	0.839	<.001	36	view →
THCA	OS	Tertile	II,III,IV	0.178	0.904	<.001	36	view →
LUAD	OS	Tertile	III,IV	0.127	0.660	.003	36	view →
STAD	DFS	Tertile	All	0.372	0.730	.001	27	view →
HNSC	OS	Tertile	All	0.280	0.662	.020	27	view →
TGCT	OS	Tertile	All	0.867	0.967	.040	18	view →
CESC	OS	Tertile	All	0.089	0.585	.025	18	view →
KIRC	DFS	Tertile	All	0.569	0.805	.036	12	view →
BLCA	DFS	Tertile	III,IV	0.167	0.473	.039	9	view →
SKCM	OS	Tertile	All	0.480	0.788	.008	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR8061–DLBC (OS)

Open the DLBC breakdown →